R&D FOCUS GROUP

NanoVision’s research and development efforts focus on the application of nanotechnologies in ophthalmology to help patient compliance to drug therapies and to remove toxicity issues associated with medical treatments.

This includes:

  • Drugs delivery systems such as the Polyvinyl Alcohol Matrix (PALM) NanoGEL sustained drug delivery platform
  • New material development programs in partnership with Contamac Ltd., UK
  • Cutting-edge design technology
  • Patient adherence systems